We pulled off an M&A triple play in 2022.

Tombstones for three transactions facilitated by Middle Branch Partners in 2022 for clients UFP Technologies, MycoScience, Ethide Laboratories, and Acrotec

2022 was a big year for Middle Branch Partners. We initiated and helped close three major transactions in the MedTech sector:

1. UFP Technologies Acquired Advant Medical Molding

In March, our client UFP Technologies acquired Advant Medical Molding in a private, non-auction deal. Based in Ireland with additional operations in Costa Rica and partner manufacturing in Mexico, the company adds global capabilities in processes and products to UFPT.

READ MORE...

2. Mycoscience and Ethide Laboratories were acquired by Millstone Medical Outsourcing

In November, our clients Mycoscience and Ethide Laboratories were acquired by Millstone Medical Outsourcing, the industry's leading partner of choice for medical manufacturers' post-manufacturing and aftermarket services.

READ MORE...

3. Acrotec Group, a portfolio company of The Carlyle Group based in Switzerland, acquired Axial Medical

Shortly after the Mycoscience deal, our client Acrotec Group, a portfolio company of The Carlyle Group, agreed to acquire Axial Medical, a precision MedTech manufacturer in Warminster Pennsylvania.

READ MORE...


We are proud of all of the great work we were able to accomplish for our clients last year, and are looking forward to a busy, productive 2023. How can Middle Branch Partners help your business achieve its M&A objectives this year? Contact us today to find out.

Previous
Previous

MD&M West Is On!

Next
Next

Acrotec Group agrees to acquire Axial Medical